Schinazi Raymond F
Insider CIK 1397607 · DTIL Director · COCP Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DTIL PRECISION BIOSCIENCES INC | A Award deriv | 2022-05-10 | 2022-05-12 | 156,951 | — | $0 | 156,951 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | A Award deriv | 2021-05-10 | 2021-05-12 | 32,800 | — | $0 | 32,800 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | S Sale | 2021-05-04 | 2021-05-06 | 575,000 | $2.95 | $1.70M | 7,674,960 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | A Award deriv | 2020-05-13 | 2020-05-15 | 41,038 | — | $0 | 41,038 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2019-10-25 | 2019-10-29 | 7,906 | $1.15 | $9.1K | 9,257,863 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2019-10-24 | 2019-10-29 | 5,094 | $1.15 | $5.9K | 9,249,957 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2019-10-23 | 2019-10-29 | 3,935 | $1.04 | $4.1K | 9,244,863 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion deriv | 2019-04-01 | 2019-04-02 | 119,761 | — | $0 | 0 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion deriv | 2019-04-01 | 2019-04-02 | 0 | — | $0 | 0 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion | 2019-04-01 | 2019-04-02 | 36,946 | $13.60 | $502.5K | 36,946 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion | 2019-04-01 | 2019-04-02 | 56,102 | — | $0 | 93,048 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | A Award deriv | 2019-03-27 | 2019-03-29 | 34,544 | — | $0 | 34,544 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | J Other deriv | 2019-03-27 | 2019-03-29 | 0 | $500000.00 | $0 | 0 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award deriv | 2018-09-21 | 2018-09-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | D To issuer deriv | 2018-05-10 | 2018-05-14 | 61,728 | $500000.00 | $30.86B | 61,728 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award deriv | 2018-05-10 | 2018-05-14 | 263,158 | $500000.00 | $131.58B | 263,158 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | M Exercise deriv | 2018-05-10 | 2018-05-14 | 263,158 | $500000.00 | $131.58B | 263,158 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | M Exercise | 2018-05-10 | 2018-05-14 | 263,158 | $1.90 | $500.0K | 985,384 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award | 2018-05-10 | 2018-05-14 | 10,209 | $1.90 | $19.4K | 995,593 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award | 2018-05-03 | 2018-05-07 | 420,737 | $1.90 | $799.4K | 722,226 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award deriv | 2017-11-24 | 2017-12-08 | 1,851,851 | $500000.00 | $925.93B | 1,851,851 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | M Exercise deriv | 2017-07-11 | 2017-07-13 | 1,706,978 | — | $0 | 0 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | M Exercise | 2017-07-11 | 2017-07-13 | 1,706,978 | $0.05 | $85.3K | 277,227,831 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award | 2017-04-20 | 2017-04-24 | 4,166,667 | $0.24 | $1.00M | 9,044,717 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2016-09-01 | 2016-09-06 | 4,878,050 | $0.41 | $2.00M | 4,878,050 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2016-03-15 | 2016-03-17 | 2,941,176 | $0.51 | $1.50M | 275,520,853 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2015-04-21 | 2015-04-23 | 3,464,855 | $0.92 | $3.19M | 272,579,677 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award deriv | 2015-04-13 | 2015-04-15 | 350,000 | — | $0 | 350,000 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | M Exercise deriv | 2015-03-03 | 2015-03-05 | 789,747 | — | $0 | 0 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | M Exercise | 2015-03-03 | 2015-03-05 | 269,114,822 | — | $0 | 269,114,822 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award deriv | 2014-11-25 | 2014-12-05 | 798,747 | — | $0 | 798,747 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award deriv | 2014-11-25 | 2014-12-05 | 1,706,978 | — | $0 | 1,706,978 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award deriv | 2014-11-25 | 2014-12-05 | 1,706,978 | — | $0 | 1,706,978 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award deriv | 2014-11-25 | 2014-12-05 | 1,706,978 | — | $0 | 1,706,978 | SEC↗ |